ANALYTICAL METHOD DEVELOPMENT FOR THE ESTIMATION OF DARUNAVIR BY DIAZOTIZATION AND COUPLING BY VISIBLE SPECTROPHOTOMETRY
DOI:
https://doi.org/10.22159/ajpcr.2018.v11i11.27830Keywords:
Darunavir, Chromotropic acid, Bratton Marshall reagent, NilAbstract
Objectives: This proposed work describes simple and extraction free visible methods for the estimation of darunavir ethanolate (DNV) in bulk and tablet formulations. The methodology involves diazotization of DNV with nitrous acid followed by coupling with chromotropic acid (CA) (Method A)/ Bratton Marshall Reagent (Method B)/α-naphthol (Method C) to form colored products.
Methods: All the methods were developed using a PerkinElmer (LAMBDA 25) UV–Visible spectrophotometer interfaced with UV Win lab software and 1 cm quartz cells.
Results: Spectrophotometrically, DNV is estimated at 520 nm, 544 nm, and 464 nm for the reddish-pink color produced by CA, dark violet color with NED, and dark-greenish yellow with α-naphthol, respectively. The linear relationship was observed between absorbance and the corresponding concentration of drug in the range of 100–350 μg/mL, 10–100 μg/mL, and 10–60 μg/mL for Methods A, B, and C, respectively.
Conclusion: The colorimetric methods were extensively validated as per the ICH guidelines. The developed methods were proven to be more accurate and precise by the statistical analysis.
Downloads
References
Babu GR, Rao AL, Rao JV. Development and validation of novel HPLC method for estimation of darunavir in pharmaceutical formulations. Int J Res Pharm Chem 2013;3:438-3.
Reddy BV, Jyothi G, Reddy BS, Raman NV, Reddy KS, Rambabu C. A novel stability-indicating reversed-phase high-performance liquid chromatography (HPLC) method has been developed for the quantitative determination of Darunavir ethanolate, an HIV-1 protease inhibitor. J Chromatogr Sci 2013;51:471-6.
Satyanarayana L, Naidu SV, Rao MN, Kumar A, Suresh K. A reverse phase HPLC method was developed for the estimation of darunavir in tablet dosage form. Asian J Res Pharm Sci 2011;1:74-6.
Manisha M, Pranali JG, Anuja VP, Mashish S. RP-HPLC Method for determination of darunavir in bulk and pharmaceutical preparations. Int J Pharm Sci Rev Res 2013;21:20-3.
Patel BN, Suhagia CN, Bhanubhai N, Chaganbhai NP. RP-HPLC method development and validation for estimation of darunavir ethanolate in tablet dosage form. Int J Pharm Pharm Sci 2012;4:270-4.
Mastannama SK, Sirisha VS, Alekhya G, Haritha K, Arunbabu V. New validated RP-HPLC method for estimation of darunavir in bulk and dosage form. Int Res J Pharm 2014;5:13-6.
Rao KV, Phanindra B, Rajesh K. Spectrophotometric method for estimation of darunavir ethanolate by using MBTH reagent in bulk and pharmaceutical dosage form. Inventi Rapid 2013;4:1-3.
Mastanamma SK, Sirisha VS. Validated visible spectrophotometric method for estimation of darunavir in bulk and pharmaceutical dosage form using 1, 2 naphthoquinone 4-sulphonate reagent. World J Pharm Res 2014;3:4615-24.
Vijayalakshmi R, Anjani D, Kumari SS, Bhuvaneswari S, Dhanaraju MD. Oxidative coupling method for the estimation of darunavir and capecitabine by visible spectrophotometry. Int J Pharm Tech Res 2016;9:146-74.
Vijayalakshmi R, Ramya YN, Mani AD, Dhanaraju MD. Spectrophotometric determination of darunavir ethanolate by condensation technique. Int J Pharm Tech Res 2016;9:301-6.
Deshpande BP, Santosh RB. Development and validation of stability-indicating HPTLC method for determination of darunavir ethanolate and ritonavir. Int J Pharm Pharm Sci 2015;7:66-71.
Vijayalakshmi R, Ramya YN, Dhanaraju MD. Method development for quantification of oxidation complexes of nadolol and resveratrol by visible spectrophotometry. Int J Pharm Pharm Sci 2015;5:304-7.
Jawad AA, Kadhim KH. Spectrophotometric determination of metoclopramide hydrochloride in bulk and pharmaceutical preparations by diazotization–coupling reaction. Int J Pharm Pharm Sci 2013;15:294 8.
ICH-Q2B Validation of Analytical Procedures: Methodology International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human use, Geneva, Switzerland; 1996.
Published
How to Cite
Issue
Section
The publication is licensed under CC By and is open access. Copyright is with author and allowed to retain publishing rights without restrictions.
